The Plasminogen Activator System and Cancer

Publisher： Karger

E-ISSN： 1424-8840|36|3-4|184-194

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.36, Iss.3-4, 2009-01, pp. : 184-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationship between Circulating Tumor Cells, Blood Coagulation, and Urokinase‐Plasminogen‐Activator System in Early Breast Cancer Patients

By  

THE BREAST JOURNAL, Vol. 21, Iss. 2, 2015-03 ,pp. : 155-160

John Wiley & Sons Inc

Access to resources Recommend Favorite

The combined serum levels of miR‐375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1406-1416

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plasminogen activator inhibitor-1 in kidney pathology (Review)

By      

International Journal of Molecular Medicine, Vol. 31, Iss. 3, 2013-01 ,pp. : 503-510

Spandidos Publications

Access to resources Recommend Favorite

Recurrent Pregnancy Loss and Its Relation to FV Leiden, FII G20210A and Polymorphisms of Plasminogen Activator and Plasminogen Activator Inhibitor

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 3, 2004-06 ,pp. : 134-137

Karger

Access to resources Recommend Favorite

Plasma Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Acute Myocardial Infarction

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 2, 2002-07 ,pp. : 80-84

Karger

Access to resources Recommend Favorite